Gabapentin
Product Images NDC 53002-5472

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 53002-5472). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

This appears to be a table showing the mean pain score for different treatment regimens (Parkod and Gabapentin) compared to a placebo over the course of several weeks. The first column represents the baseline score and the subsequent columns indicate scores at various weeks. The text is not complete and lacks context, making it difficult to provide more specific information.*

FDA Label Image

Figure 2 (Image 02)

This is a graph representing the results of a study on the effects of Gabapentin on pain relief. The study was conducted over a period of 6 weeks, with a fixed dose period of 4 weeks. The X-axis represents the weeks, while the Y-axis represents the mean pain score. The study compared the effects of Gabapentin with a Placebo. Two doses of Gabapentin, 1800 mg/day and 2400 mg/day, were administered to the participants. The graph indicates a significant decrease in mean pain score for participants taking Gabapentin compared to those taking a placebo.*

FDA Label Image

Figure 3 (Image 03)

FDA Label Image

Cockcroft And Gault Equation (Image 04)

FDA Label Image

Gabapentin Structural Formula (Image 05)

FDA Label Image

Image-09 (Image 09)

FDA Label Image

Label Image (Lbl530025472)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.